| 000 | 02871 a2200805 4500 | ||
|---|---|---|---|
| 005 | 20250517025950.0 | ||
| 264 | 0 | _c20150716 | |
| 008 | 201507s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(15)60616-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSax, Paul E | |
| 245 | 0 | 0 |
_aTenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 2015 |
||
| 300 |
_a2606-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenine _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlanine |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthralgia _xchemically induced |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aCarbamates _xadministration & dosage |
| 650 | 0 | 4 | _aCobicistat |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aEmtricitabine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHeadache _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNausea |
| 650 | 0 | 4 |
_aOrganophosphonates _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinolones _xadministration & dosage |
| 650 | 0 | 4 |
_aRespiration Disorders _xchemically induced |
| 650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xchemically induced |
| 650 | 0 | 4 | _aTenofovir |
| 650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aViral Load _xdrug effects |
| 700 | 1 | _aWohl, David | |
| 700 | 1 | _aYin, Michael T | |
| 700 | 1 | _aPost, Frank | |
| 700 | 1 | _aDeJesus, Edwin | |
| 700 | 1 | _aSaag, Michael | |
| 700 | 1 | _aPozniak, Anton | |
| 700 | 1 | _aThompson, Melanie | |
| 700 | 1 | _aPodzamczer, Daniel | |
| 700 | 1 | _aMolina, Jean Michel | |
| 700 | 1 | _aOka, Shinichi | |
| 700 | 1 | _aKoenig, Ellen | |
| 700 | 1 | _aTrottier, Benoit | |
| 700 | 1 | _aAndrade-Villanueva, Jaime | |
| 700 | 1 | _aCrofoot, Gordon | |
| 700 | 1 | _aCustodio, Joseph M | |
| 700 | 1 | _aPlummer, Andrew | |
| 700 | 1 | _aZhong, Lijie | |
| 700 | 1 | _aCao, Huyen | |
| 700 | 1 | _aMartin, Hal | |
| 700 | 1 | _aCallebaut, Christian | |
| 700 | 1 | _aCheng, Andrew K | |
| 700 | 1 | _aFordyce, Marshall W | |
| 700 | 1 | _aMcCallister, Scott | |
| 773 | 0 |
_tLancet (London, England) _gvol. 385 _gno. 9987 _gp. 2606-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(15)60616-X _zAvailable from publisher's website |
| 999 |
_c24821078 _d24821078 |
||